174078-98-9 Usage
General Description
Carbamic acid, (4,5-dimethyl-3-isoxazolyl)-, 1,1-dimethylethyl ester (9CI), also known as butocarboxim, is a chemical compound used as an insecticide and acaricide. It belongs to the carbamate class of pesticides and is commonly used in agriculture to control a wide range of pests including aphids, mites, and whiteflies. Butocarboxim works by inhibiting acetylcholinesterase, an enzyme essential for the proper functioning of the nervous system in insects and mites, ultimately leading to their paralysis and death. Carbamic acid, (4,5-dimethyl-3-isoxazolyl)-, 1,1-dimethylethyl ester (9CI) is considered moderately toxic to humans and other mammals and should be handled with care to avoid any adverse effects.
Check Digit Verification of cas no
The CAS Registry Mumber 174078-98-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,4,0,7 and 8 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 174078-98:
(8*1)+(7*7)+(6*4)+(5*0)+(4*7)+(3*8)+(2*9)+(1*8)=159
159 % 10 = 9
So 174078-98-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H16N2O3/c1-6-7(2)15-12-8(6)11-9(13)14-10(3,4)5/h1-5H3,(H,11,12,13)
174078-98-9Relevant articles and documents
NOVEL DUAL ACTION RECEPTORS ANTAGONISTS (DARA) AT THE AT1 AND ETA RECEPTORS
-
Page/Page column 35; 46; 57; 67; 74-75; 84; 92-93; 104; 114-115, (2010/11/28)
The present invention relates to new compounds of the formula [Chemical formula should be inserted here. Please see paper copy] wherein R1, R2, R3, and R31 are as specified herein. The invention also relates to a method for preparation thereof, as well as combinations of the new compounds with previously known agents. The invention also relates to the use of the above-mentioned compounds and combinations for the preparation of a medicament for treating hypertension of different kinds, alleviating organ damage of different kinds, treating or preventing diabetic nephropathy, treating endothelin and angiotensin mediated disorders, and treating prostate cancer.
Directed lithiation of N-(tert-butoxycarbonyl)aminoisoxazole: Synthesis of 4-substituted aminoisoxazoles
Konoike, Toshiro,Kanda, Yasuhiko,Araki, Yoshitaka
, p. 3339 - 3342 (2007/10/03)
Directed lithiation of 3-(Boc-amino)isoxazole 4 and 5-(Boc-amino)isoxazole 9 is described. Dilithioisoxazoles reacted with a variety of electrophiles to give the corresponding 4-substituted isoxazoles.